NEW BRUNSWICK, N.J. (AP) - Johnson & Johnson has given the Food and Drug Administration additional data to on its new anticlotting drug, in a second attempt to get approval for more uses.
Xarelto is approved for reducing risk of blood clots in people who've had knee or hip replacement surgery and reducing stroke risk in people with an irregular heartbeat.
J&J sought approval to market Xarelto for preventing a second heart attack or stroke in patients at high risk because of a narrowed heart artery, and for preventing blood clots from forming around stents, tiny metal-mesh scaffolds that prop open heart arteries.
The FDA turned down one application in June. J&J then withdrew the second. Now it's sent the FDA data from a huge study showing Xarelto prevented strokes, heart attacks and deaths.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
A Parke County accident kills one, and sends another to the hospital.
Court Documents show what led to the murder of 17 year old Devan Burris of Washington, Indiana.
A November case of armed robbery lands one man behind bars. The suspect appeared in court Monday morning.
Vincennes city leaders are moving forward, once again, to try to demolish the Executive Inn.
New rules in Indiana mean some people won't be able to count on their food stamps, like clock-work.
Charges have been filed against a mother in an Effingham County, Illinois murder case.